VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
tirzepatide우선순위 낮음근거 검토리뷰

LITERATURE DETAIL · PMID 42634284

Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy.

Responders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy.

저자
Alina Kuryłowicz, Leszek Czupryniak
저널
Diabetes, obesity & metabolism
공개일
2026 Aug 23
연구 유형
리뷰
DOI
10.1111/dom.71226

문헌 요약

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual GLP-1/GIP receptor agonists have transformed the pharmacological management of type 2 diabetes (T2D) and obesity, yet substantial interindividual variability in treatment response remains a defining clinical challenge. Narrative review. PubMed was searched to 25 May 2026 (English language, huma…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기